Drug Type Monoclonal antibody |
Synonyms CK 303, CK303 |
Target |
Mechanism CAIX inhibitors(Carbonic anhydrase IX inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Phagocytes stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Preclinical | US | 02 Aug 2020 |